Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix Shares Spike 20 Percent

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Shares of CombiMatrix today jumped as much as 20 percent today on Nasdaq.

By late afternoon, the company's stock had gone as high as $3.88 per share as more than 37,000 shares were traded, more than four times CombiMatrix's average daily volume of 9,029 shares during the past three months.

At the close of the market on Thursday, CombiMatrix shares were up almost 16 percent to $3.73. Nearly 41,000 shares exchanged hands.

The reason for the share and volume increase was unclear.

Two weeks ago, CombiMatrix reported $912,000 in first-quarter revenues, an 11 percent increase year over year.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.